Joan edukira
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Hizkuntza
Eremu guztiak
Izenburua
Egilea
Gaia
Sailkapena
ISBN/ISSN
Etiketa
Bilatu
Aurreratua
A SYSTEMATIC REVIEW AND META-A...
Erreferentzia bihurtu
SMS
Bidali
Imprimir
Erregistroa esportatu
Nora RefWorks
Nora EndNoteWeb
Nora EndNote
Permanent link
A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (RCTS) OF EGFR-TARGETED MONOCLONAL ANTIBODY (MAB) THERAPY IN ADVANCED COLORECTAL CANCER (ACRC): IMPACT OF K-RAS STATUS
Xehetasun bibliografikoak
Egile Nagusiak:
Vale, C
,
Tierney, J
,
Meade, A
,
Fisher, D
,
Kaplan, R
,
Adams, R
,
Maughan, T
,
Parmar, M
Formatua:
Journal article
Argitaratua:
2009
Aleari buruzko argibideak
Deskribapena
Antzeko izenburuak
MARC erregistroa
Antzeko izenburuak
Impact of K-ras status on the effects of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): A systematic review and meta-analysis of randomized controlled trials (RCTs)
nork: Vale, C, et al.
Argitaratua: (2009)
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.
nork: Vale, C, et al.
Argitaratua: (2012)
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
nork: Vale, C, et al.
Argitaratua: (2012)
THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
nork: Maughan, T, et al.
Argitaratua: (2010)
Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
nork: Maughan, T, et al.
Argitaratua: (2009)